(EPC) Edgewell Personal Care - Ratings and Ratios
Razors, Shaving Systems, Sunscreens, Lotions, Wipes
EPC EPS (Earnings per Share)
EPC Revenue
Description: EPC Edgewell Personal Care
Edgewell Personal Care Co (NYSE:EPC) is a US-based company operating in the Personal Care Products sub-industry. To understand the companys financial health, examining its yearly Income Tax Expense is crucial. A thorough analysis of this aspect can reveal insights into the companys tax strategy and its impact on profitability.
The companys market capitalization stands at $1.023 billion, indicating a mid-cap status. The Price-to-Earnings (P/E) ratio is 16.32, suggesting that the stock is relatively fairly valued compared to its earnings. However, the Forward P/E ratio is significantly lower at 8.15, implying expected earnings growth. The Return on Equity (RoE) is 4.20%, a relatively modest return that may indicate room for improvement in generating profits from shareholder equity.
Key economic drivers for Edgewell Personal Care Co include consumer demand for personal care products, competition within the industry, and macroeconomic factors such as inflation and interest rates. The companys performance is also influenced by its ability to innovate and adapt to changing consumer preferences. Key Performance Indicators (KPIs) to monitor include revenue growth, gross margin, and operating cash flow, which can provide insights into the companys operational efficiency and ability to generate cash.
To further analyze Edgewell Personal Care Cos stock, its essential to consider its valuation multiples, profitability metrics, and cash flow generation. Comparing these metrics to industry peers and benchmarks can help identify areas of strength and weakness. Additionally, monitoring industry trends, such as the shift towards sustainable and natural personal care products, can provide context for the companys future prospects.
EPC Stock Overview
| Market Cap in USD | 1,065m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 2000-03-27 |
EPC Stock Ratings
| Growth Rating | -44.2% |
| Fundamental | 54.5% |
| Dividend Rating | 46.7% |
| Return 12m vs S&P 500 | -47.9% |
| Analyst Rating | 3.78 of 5 |
EPC Dividends
| Dividend Yield 12m | 2.74% |
| Yield on Cost 5y | 2.82% |
| Annual Growth 5y | 31.95% |
| Payout Consistency | 61.2% |
| Payout Ratio | 23.3% |
EPC Growth Ratios
| Growth Correlation 3m | -37.6% |
| Growth Correlation 12m | -94.8% |
| Growth Correlation 5y | -16.3% |
| CAGR 5y | -2.01% |
| CAGR/Max DD 5y | -0.03 |
| Sharpe Ratio 12m | -0.57 |
| Alpha | -49.56 |
| Beta | 0.510 |
| Volatility | 41.95% |
| Current Volume | 506.3k |
| Average Volume 20d | 598.6k |
| Stop Loss | 23.2 (-3.4%) |
| Signal | 1.71 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (64.8m TTM) > 0 and > 6% of Revenue (6% = 132.2m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -3.08pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.84% (prev 18.66%; Δ 1.18pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 118.0m > Net Income 64.8m (YES >=105%, WARN >=100%) |
| Net Debt (1.21b) to EBITDA (179.5m) ratio: 6.76 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (48.0m) change vs 12m ago -4.19% (target <= -2.0% for YES) |
| Gross Margin 42.16% (prev 42.77%; Δ -0.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.76% (prev 61.22%; Δ -2.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.24 (EBITDA TTM 179.5m / Interest Expense TTM 75.9m) >= 6 (WARN >= 3) |
Altman Z'' 2.63
| (A) 0.12 = (Total Current Assets 1.00b - Total Current Liabilities 567.4m) / Total Assets 3.79b |
| (B) 0.30 = Retained Earnings (Balance) 1.12b / Total Assets 3.79b |
| (C) 0.07 = EBIT TTM 246.1m / Avg Total Assets 3.75b |
| (D) 0.45 = Book Value of Equity 998.2m / Total Liabilities 2.23b |
| Total Rating: 2.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.49
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 1.87% = 0.94 |
| 3. FCF Margin 1.94% = 0.48 |
| 4. Debt/Equity 0.90 = 2.11 |
| 5. Debt/Ebitda 7.87 = -2.50 |
| 6. ROIC - WACC 2.78% = 3.47 |
| 7. RoE 4.20% = 0.35 |
| 8. Rev. Trend 18.37% = 0.92 |
| 9. Rev. CAGR 5.82% = 0.73 |
| 10. EPS Trend -9.96% = -0.25 |
| 11. EPS CAGR -2.06% = -0.26 |
What is the price of EPC shares?
Over the past week, the price has changed by +0.25%, over one month by -7.01%, over three months by -12.76% and over the past year by -39.07%.
Is Edgewell Personal Care a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EPC is around 21.65 USD . This means that EPC is currently overvalued and has a potential downside of -9.87%.
Is EPC a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the EPC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26 | 8.2% |
| Analysts Target Price | 32.4 | 34.8% |
| ValueRay Target Price | 23.2 | -3.5% |
Last update: 2025-08-19 02:48
EPC Fundamental Data Overview
CCE Cash And Equivalents = 199.6m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.9852
P/E Forward = 8.4818
P/S = 0.4834
P/B = 0.6795
P/EG = 2.39
Beta = 0.818
Revenue TTM = 2.20b USD
EBIT TTM = 246.1m USD
EBITDA TTM = 179.5m USD
Long Term Debt = 1.37b USD (from longTermDebt, last quarter)
Short Term Debt = 39.5m USD (from shortTermDebt, last quarter)
Debt = 1.41b USD (Calculated: Short Term 39.5m + Long Term 1.37b)
Net Debt = 1.21b USD (from netDebt column, last quarter)
Enterprise Value = 2.28b USD (1.07b + Debt 1.41b - CCE 199.6m)
Interest Coverage Ratio = 3.24 (Ebit TTM 246.1m / Interest Expense TTM 75.9m)
FCF Yield = 1.87% (FCF TTM 42.7m / Enterprise Value 2.28b)
FCF Margin = 1.94% (FCF TTM 42.7m / Revenue TTM 2.20b)
Net Margin = 2.94% (Net Income TTM 64.8m / Revenue TTM 2.20b)
Gross Margin = 42.16% ((Revenue TTM 2.20b - Cost of Revenue TTM 1.27b) / Revenue TTM)
Tobins Q-Ratio = 2.28 (Enterprise Value 2.28b / Book Value Of Equity 998.2m)
Interest Expense / Debt = 1.37% (Interest Expense 19.4m / Debt 1.41b)
Taxrate = 18.44% (from yearly Income Tax Expense: 22.3m / 120.9m)
NOPAT = 200.7m (EBIT 246.1m * (1 - 18.44%))
Current Ratio = 1.77 (Total Current Assets 1.00b / Total Current Liabilities 567.4m)
Debt / Equity = 0.90 (Debt 1.41b / last Quarter total Stockholder Equity 1.57b)
Debt / EBITDA = 7.87 (Net Debt 1.21b / EBITDA 179.5m)
Debt / FCF = 33.07 (Debt 1.41b / FCF TTM 42.7m)
Total Stockholder Equity = 1.54b (last 4 quarters mean)
RoA = 1.71% (Net Income 64.8m, Total Assets 3.79b )
RoE = 4.20% (Net Income TTM 64.8m / Total Stockholder Equity 1.54b)
RoCE = 8.44% (Ebit 246.1m / (Equity 1.54b + L.T.Debt 1.37b))
RoIC = 6.81% (NOPAT 200.7m / Invested Capital 2.95b)
WACC = 4.03% (E(1.07b)/V(2.48b) * Re(7.89%)) + (D(1.41b)/V(2.48b) * Rd(1.37%) * (1-Tc(0.18)))
Shares Correlation 5-Years: -100.0 | Cagr: -3.35%
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 76.27% ; FCFE base≈88.1m ; Y1≈77.5m ; Y5≈63.6m
Fair Price DCF = 24.86 (DCF Value 1.16b / Shares Outstanding 46.5m; 5y FCF grow -14.76% → 3.0% )
Revenue Correlation: 18.37 | Revenue CAGR: 5.82%
Rev Growth-of-Growth: -3.11
EPS Correlation: -9.96 | EPS CAGR: -2.06%
EPS Growth-of-Growth: -40.25
Additional Sources for EPC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle